The most common current therapy involves administration of estrogen.

These agents have several theoretical advantages over current therapy.

A new study shows that the drugs can work just as well or even better than current therapies without dangerous side effects.

The drug could cost as little as £350 annually, much less than the £10,000-a-year price tag of the current therapy.

The new findings challenge many assumptions underlying current therapy.

If prostate cancer has spread to distant organs, current therapy will not cure it.

Diabetics will soon be able to choose a new type of insulin that promises to work faster than current therapy.

Although the disease was previously considered to be progressive throughout life, current therapies have significantly improved its outlook.

Generally they must save or enhance lives and offer an advance on current therapy.

However, current therapies are imperfect and there is a strong need for new research and attention.